268 related articles for article (PubMed ID: 29979258)
1. Autoimmune haemolytic anaemia and autoimmune thrombocytopenia in childhood-onset systemic lupus erythematosus: updates on pathogenesis and treatment.
Neely J; von Scheven E
Curr Opin Rheumatol; 2018 Sep; 30(5):498-505. PubMed ID: 29979258
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
Serris A; Amoura Z; Canouï-Poitrine F; Terrier B; Hachulla E; Costedoat-Chalumeau N; Papo T; Lambotte O; Saadoun D; Hié M; Blanche P; Lioger B; Gottenberg JE; Godeau B; Michel M
Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
[TBL] [Abstract][Full Text] [Related]
3. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.
Olfat M; Silverman ED; Levy DM
Lupus; 2015 Aug; 24(9):966-72. PubMed ID: 25804672
[TBL] [Abstract][Full Text] [Related]
4. Correspondence on 'Risk of systemic lupus erythematosus after immune thrombocytopenia and autoimmune haemolytic anaemia: a nationwide French study'.
Maquet J; Lafaurie M; Sailler L; Lapeyre-Mestre M; Moulis G
Ann Rheum Dis; 2023 Apr; 82(4):e95. PubMed ID: 33310730
[No Abstract] [Full Text] [Related]
5. Response to: 'Correspondence on 'Risk of systemic lupus erythematosus after immune thrombocytopenia and autoimmune haemolytic anaemia: a nationwide French study'' by Maquet
Chen XH; Wei JCC; Mo HY; Chen HH
Ann Rheum Dis; 2023 Apr; 82(4):e96. PubMed ID: 33310729
[No Abstract] [Full Text] [Related]
6. Anticardiolipin antibodies, haemolytic anaemia and thrombocytopenia in systemic lupus erythematosus.
Fong KY; Loizou S; Boey ML; Walport MJ
Br J Rheumatol; 1992 Jul; 31(7):453-5. PubMed ID: 1628167
[TBL] [Abstract][Full Text] [Related]
7. Response to: 'Correspondence on 'Risk of systemic lupus erythematosus after immune thrombocytopenia and autoimmune haemolytic anaemia: a nationwide French study'' by Maquet
Chen XH; Zhu FX; Chen HH; Wei JC
Ann Rheum Dis; 2023 Apr; 82(4):e97. PubMed ID: 33441296
[No Abstract] [Full Text] [Related]
8. Autoimmune haemolytic anaemia and thrombocytopaenia in a single-centre cohort of patients with systemic lupus erythematosus from Turkey: clinical associations and effect on disease damage and survival.
Artım-Esen B; Çene E; Şahinkaya Y; Erdugan M; Oğuz E; Gül A; Öcal L; İnanç M
Lupus; 2019 Oct; 28(12):1480-1487. PubMed ID: 31558101
[TBL] [Abstract][Full Text] [Related]
9. Low-dose rituximab therapy in steroid-refractory thrombocytopenia due to systemic lupus erythematosus.
Ilizaliturri-Guerra O; Uriarte-Botello R; Pineda-Sic RÁ; Serna-Peña G; Garza-Elizondo MA; Galarza-Delgado DÁ; Leal-Bramasco AS; Elizondo-Solís CV; Santoyo-Fexas L; Villarreal-Alarcón MÁ
Rheumatol Int; 2020 Oct; 40(10):1717-1724. PubMed ID: 32797277
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD20 monoclonal antibody in acute life threatening haemolytic anaemia complicating childhood onset SLE.
Abdwani R; Mani R
Lupus; 2009 Apr; 18(5):460-4. PubMed ID: 19318402
[TBL] [Abstract][Full Text] [Related]
11. Significance of autoimmune haemolytic anaemia and immune thrombocytopenia (Evans' syndrome) in systemic lupus erythematosus.
Pasangna J; Lim CB; Duraisamy G; Lajin I
Malays J Pathol; 1994 Jun; 16(1):79-82. PubMed ID: 16329581
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems.
Sultan SM; Begum S; Isenberg DA
Rheumatology (Oxford); 2003 Feb; 42(2):230-4. PubMed ID: 12595615
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus.
Perrotta S; Locatelli F; La Manna A; Cennamo L; De Stefano P; Nobili B
Br J Haematol; 2002 Feb; 116(2):465-7. PubMed ID: 11841453
[TBL] [Abstract][Full Text] [Related]
14. Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus.
So MW; Koo BS; Kim YJ; Kim YG; Lee CK; Yoo B
Mod Rheumatol; 2014 Sep; 24(5):855-7. PubMed ID: 24517558
[TBL] [Abstract][Full Text] [Related]
15. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M
J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
[TBL] [Abstract][Full Text] [Related]
16. Expanded utilization of rituximab in paediatric cardiac transplant patients.
Kiskaddon AL; Landmesser K; Carapellucci J; Wisotzkey B; Asante-Korang A
J Clin Pharm Ther; 2021 Jun; 46(3):762-766. PubMed ID: 33393702
[TBL] [Abstract][Full Text] [Related]
17. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
[TBL] [Abstract][Full Text] [Related]
18. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
[TBL] [Abstract][Full Text] [Related]
19. Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment.
Giannouli S; Voulgarelis M; Ziakas PD; Tzioufas AG
Ann Rheum Dis; 2006 Feb; 65(2):144-8. PubMed ID: 16079164
[TBL] [Abstract][Full Text] [Related]
20. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation.
Raj K; Narayanan S; Augustson B; Ho A; Mehta P; Duncan N; Tauro S; Mahendra P; Craddock C; Mufti G
Bone Marrow Transplant; 2005 Feb; 35(3):299-301. PubMed ID: 15568036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
